Shopping Cart
Remove All
Your shopping cart is currently empty
EGFR-IN-107 (compound 3r) is an orally active EGFR inhibitor with IC50 values of 0.4333 μM for EGFRWT and 0.0438 μM for EGFRL858R/T790M. It exhibits antiproliferative activity, effectively inhibiting the proliferation of H1975 cells and inducing apoptosis (apoptosis). EGFR-IN-107 is applicable in cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | EGFR-IN-107 (compound 3r) is an orally active EGFR inhibitor with IC50 values of 0.4333 μM for EGFRWT and 0.0438 μM for EGFRL858R/T790M. It exhibits antiproliferative activity, effectively inhibiting the proliferation of H1975 cells and inducing apoptosis (apoptosis). EGFR-IN-107 is applicable in cancer research. |
| In vitro | EGFR-IN-107 has an IC50 value of 5 nM against the EGFR L858R/T790M kinase. Its IC50 value against the Osimertinib-resistant H1975 cell line (H1975OR) is 1.9 μM. Additionally, at a concentration of 1 μM for 24 hours, EGFR-IN-107 induces apoptosis and inhibits cell migration in H1975 cells. |
| In vivo | EGFR-IN-107 (compound 3r), administered orally at doses of 5, 10, and 20 mg/kg for 21 days, demonstrates strong antitumor activity and significantly inhibits proliferation in the H1975 xenograft mouse model. |
| Formula | C34H36FN7O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.